Peer review reports
From: Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinoma
Original Submission |
1 Sep 2021 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
28 Sep 2021 |
Reviewed |
Reviewer Report
|
28 Sep 2021 |
Reviewed |
Reviewer Report
|
12 Nov 2021 |
Reviewed |
Reviewer Report
|
4 Dec 2021 |
Author responded |
Author comments - Tao Peng
|
Resubmission - Version 5 |
4 Dec 2021 |
Submitted |
Manuscript version 5
|
14 Dec 2021 |
Author responded |
Author comments - Tao Peng
|
Resubmission - Version 6 |
14 Dec 2021 |
Submitted |
Manuscript version 6
|
23 Dec 2021 |
Author responded |
Author comments - Tao Peng
|
Resubmission - Version 7 |
23 Dec 2021 |
Submitted |
Manuscript version 7
|
7 Feb 2022 |
Reviewed |
Reviewer Report
|
Resubmission - Version 8 |
|
Submitted |
Manuscript version 8
|
Publishing |
11 Feb 2022 |
Editorially accepted |
|
22 Feb 2022 |
Article published |
10.1186/s12876-022-02152-w
|
Learn about peer review